Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
25,016
-
Shares change
-
+5,602
-
Total reported value, excl. options
-
$145,622
-
Value change
-
+$20,768
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$5.83
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q1 2024
12 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q1 2024.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,016 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (12,598 shares), CITADEL ADVISORS LLC (11,076 shares), Tower Research Capital LLC (TRC) (1,002 shares), CoreCap Advisors, LLC (200 shares), OSAIC HOLDINGS, INC. (84 shares), Federation des caisses Desjardins du Quebec (37 shares), TORONTO DOMINION BANK (7 shares), WELLS FARGO & COMPANY/MN (6 shares), MORGAN STANLEY (4 shares), and ST GERMAIN D J CO INC (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.